Prospective pilot study with [89Zr]Zr-girentuximab PET/CT: CA-IX imaging in metastatic triple negative breast cancer (OPALESCENCE)
- DOI
- 10.1007/s00259-025-07619-y
- Published
- 2025-11-01
- Container
- European Journal of Nuclear Medicine and Molecular Imaging
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00259-025-07619-y,
title = {Prospective pilot study with [89Zr]Zr-girentuximab PET/CT: CA-IX imaging in metastatic triple negative breast cancer (OPALESCENCE)},
author = {Caroline Rousseau and M. F. Heyman and L. Ferrer and A. Rauscher and A. Morel and D. Rusu and JS Frenel and M. Taupin and L. Vilcot and N. Allam and M. Robert and M. Campone and L. Campion and F. Kraeber-Bodéré},
year = {2025},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
doi = {10.1007/s00259-025-07619-y},
url = {https://doi.org/10.1007/s00259-025-07619-y}
}RIS
TY - JOUR TI - Prospective pilot study with [89Zr]Zr-girentuximab PET/CT: CA-IX imaging in metastatic triple negative breast cancer (OPALESCENCE) AU - Caroline Rousseau AU - M. F. Heyman AU - L. Ferrer AU - A. Rauscher AU - A. Morel AU - D. Rusu AU - JS Frenel AU - M. Taupin AU - L. Vilcot AU - N. Allam AU - M. Robert AU - M. Campone AU - L. Campion AU - F. Kraeber-Bodéré PY - 2025 JO - European Journal of Nuclear Medicine and Molecular Imaging DO - 10.1007/s00259-025-07619-y UR - https://doi.org/10.1007/s00259-025-07619-y ER -
APA
Rousseau, C., Heyman, M. F., Ferrer, L., Rauscher, A., Morel, A., Rusu, D., Frenel, J., Taupin, M., Vilcot, L., Allam, N., Robert, M., Campone, M., Campion, L., & Kraeber-Bodéré, F. (2025). Prospective pilot study with [89Zr]Zr-girentuximab PET/CT: CA-IX imaging in metastatic triple negative breast cancer (OPALESCENCE). European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-025-07619-y
Source records
- crossref · retrieved 2026-09-25T10:30:13.459Z